イギリス【NHS】 新生児血液スポット検査に関するFAQ Newborn blood spot screening FAQs

Newborn blood spot screening FAQs
All your questions about the newborn blood spot (heel prick) test answered, including what happens to your baby's blood spot card and why a second sample may be...

All your questions about newborn blood spot screening answered, including what happens to your baby’s blood spot card and why a second sample is sometimes needed.

Why does blood have to be taken when babies are only about a week old?なぜ、生後1週間程度で採血をしなければならないのか?

Every baby is offered newborn blood spot screening, also known as the heel prick test, ideally when they are 5 days old. Newborn babies are screened for:

・sickle cell disease
・cystic fibrosis
・congenital hypothyroidism
・phenylketonuria (PKU)
・medium-chain acyl-CoA dehydrogenase deficiency (MCADD)
・maple syrup urine disease
・isovaleric acidaemia
・glutaric aciduria type 1

This is the best time to test for all the conditions together. It allows time to get the results back, do diagnostic tests if required and start any necessary treatment early.
If babies were tested later, some babies might suffer harm that could have been avoided if they had been tested earlier.

Babies who are new to the country or are yet to have a heel prick test are able to have the test at any time up to 1 year old. However, this does not include the cystic fibrosis screening test, which is not reliable after 8 weeks of age.

Newborn siblings of children affected by 1 of the conditions can be tested for that specific condition earlier than 5 days old. Another sample can then be taken on day 5 to screen for the other conditions.

When should premature babies be screened?:未熟児検診はいつ受けるべきか?

Babies admitted to hospital before day 5, perhaps because they are premature or unwell, should have a blood spot sample taken on admission. This sample will be used to screen for sickle cell disease in case the baby has a blood transfusion.

Babies who are premature or unwell, or have had blood transfusions, should have the usual blood spot sample taken on day 5. This blood sample is recorded on the blood spot card, along with other information.

If a baby is born before 32 weeks, an additional test is needed for congenital hypothyroidism at 28 days of age or when they are discharged from hospital, whichever is sooner. The British Thyroid Foundation has more information about congenital hypothyroidism.

Congenital hypothyroidism
Learn about congenital hypothyroidism, symptoms, diagnosis and treatment options

When is a second sample needed?:二度目のサンプルはどのような場合に必要ですか?

Occasionally, your midwife or health visitor will contact you and ask to take a second blood sample from your baby’s heel. This may be because not enough blood was collected, or the result was borderline or unclear.

It may also be because your baby was premature. In babies born before 32 weeks of pregnancy, testing on day 5 may not pick up congenital hypothyroidism. It’s advisable to have another test – either at 28 days of age or before your baby is discharged home, whichever is sooner. The repeat results are usually normal.

Are any of the conditions tested for during pregnancy?:妊娠中に検査する疾患はあるか?

During pregnancy, you will be screened for sickle cell disease. It’s possible to screen for carriers of cystic fibrosis in pregnancy, but this is not currently done in the UK.

I have been told my baby is a carrier. What does this mean for my baby and my family?:赤ちゃんはキャリアだと言われた。このことは、赤ちゃんや家族にとってどのような意味を持つのか?

Carrier status is very common and does not mean your baby will become ill.

For your baby:赤ちゃんのために

They should still be healthy. Further tests are sometimes needed to confirm cystic fibrosis carrier status. You can arrange these through a GP. See more about being a carrier of cystic fibrosis on the GOV.UK website.

Cystic fibrosis carrier: description in brief
Information for parents to explain what it means to have a positive screening result for carrying the cystic fibrosis (CF) gene.

Sickle cell disease carrier results are usually more straightforward. Your midwife or GP will tell you if further tests have been recommended, and they can arrange these. Read more about when your baby carries a gene for sickle cell on the GOV.UK website.

Baby at risk of having sickle cell disease: description in brief
Information to help healthcare professionals speak with parents at risk of having a child with sickle cell disease.

For your family:家族のために

A baby may be a carrier because one of the parents is. This is quite common and should not affect their health.

Rarely, a baby may be a carrier because both their parents are, but they have inherited the gene from only one parent. If both parents are carriers, there is a 1 in 4 chance that a future brother or sister may inherit 2 altered genes and have an inherited disease.

Currently, you will be offered testing for sickle cell disease in pregnancy, so new mothers should already know if they are carriers. A genetic counsellor can explain this in more detail and arrange tests for you if you’re concerned.

If we move to a new area, will health professionals need proof that my baby has had the screening test?:新しい地域に引っ越す場合、医療関係者は、赤ちゃんがスクリーニング検査を受けたことを証明する必要があるのか?

If you move to a new area while your baby is less than 1 year old, you will need to provide confirmation to a GP or health visitor that they have been screened. This could be a written copy of their results, or results written in the personal child health record.

If you have moved from abroad and no proof of testing is available, retesting can be discussed with you and arranged with your consent.

What are newborn blood spot cards?:新生児血液スポットカードとは何か?

As well as being used to take blood samples, these cards record personal information, including a baby’s name, date of birth, address and NHS number; the mother’s name; and contact details of the GP and midwife. These are needed to make sure the results of the screening tests are matched to the right baby.

What happens to my baby’s blood spot card?

After screening, the blood spot cards are stored for at least 5 years. They may be used:

・to double check your baby’s screening result
・to carry out other tests recommended by a doctor
・to investigate genetic diseases that run in your family
・to improve the newborn-screening programme
・for research to help improve the health of other babies and their families in UK

This research will not identify your baby, and the use of these blood spots is covered by a code of practice, which is available from your midwife or can be seen on the GOV.UK website.

Newborn blood spot screening: code of practice for residual spots
Provides the code of practice for the retention and storage of residual spots after newborn blood spot testing.

There is a small chance researchers may want to invite you or your child to take part in research linked to this screening programme. If you do not want to be invited, please let your midwife know.

If it looks like you or your baby has sickle cell disease or thalassaemia, information will be passed to the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS). This helps to improve screening and prevention or treatment of the condition.

You can find out more about why blood spot cards are stored and how your baby’s personal information is protected in Newborn blood spot cards explained.

National Disease Registration Service (NDRS) - NHS Digital
The National Disease Registration Service (NDRS) is an international leader in population-based disease registration services, real-world clinical data, quality...

イギリス【NHS】 新生児検診 Newborn screening